Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study

The optimal therapeutic options, adding locoregional therapy (LRT) to systemic therapy (ST) or not, for patients with oligometastatic breast cancer (OMBC) have not been fully elucidated. Hence, we designed a retrospective observational study which enrolled patients with measurable extracranial OMBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuyu, Duan, Fangfang, Zhuang, Yue, Song, Chenge, Huang, Jiajia, Xia, Wen, Hong, Ruoxi, Zheng, Qiufan, Wang, Shusen, Shi, Yanxia, Xu, Fei, Yuan, Zhongyu, Bi, Xiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553526/
https://www.ncbi.nlm.nih.gov/pubmed/36245976
http://dx.doi.org/10.1155/2022/7839041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553526/
https://www.ncbi.nlm.nih.gov/pubmed/36245976
http://dx.doi.org/10.1155/2022/7839041

Ejemplares similares